MedPage Today on MSN1d
Trial Data Shed Light on ALS Clinical ResearchThe phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback